Skip to main content
Terug
Watch Compare

P3 Health Partners Inc.

Datakwaliteit: 100%
Ook genoteerd als PIIIW Nasdaq
PIII
Nasdaq Services Health Services
€ 2,54
▼ € 0,10 (-3,79%)
Marktkapitalisatie: 537,14 M
Prijs
€ 2,64
Marktkapitalisatie
537,14 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -122,87 M
Capital efficient — spends only 0,01% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)18,48%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-1016,92%
Onder sectorgemiddelde (-15,74%)
ROIC-82,75%
Net Margin-9,07%
Op. Margin-17,64%

Veiligheid

Debt / Equity
N/A
Current Ratio0,32
Interest Coverage-5,51

Waardering

PE (TTM)
-4,10
Onder sectorgemiddelde (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (502 peers)
Metriek Aandeel Sector Mediaan
P/E -4,1 -1,2
P/B — 1,4
ROE % -1016,9 -15,7
Net Margin % -9,1 -18,3
Rev Growth 5Y % — 3,8
D/E — 0,4

Koersdoel Analisten

2 analisten
Buy
Huidig
€ 2,54
+37.8%
Koersdoel
€ 3,50
€ 3,00
€ 3,50
€ 4,00
Vooruitzicht
Forward WPA -€ 2,57
Omzet Sch. 1,60 B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 2,57
-€ 2,57 – -€ 2,57
 1,60 B 1
FY2026 -€ 9,44
-€ 10,29 – -€ 8,58
 1,55 B 2

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 9,47 -€ 23,02 -143,2%
Q32025 -€ 6,04 -€ 9,67 -60,2%
Q22025 -€ 4,30 -€ 6,23 -44,9%
Q12025 -€ 7,92 -€ 6,28 +20,7%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 18,48% Revenue Growth (3Y) 405,31%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,44 B Net Income (TTM) -131,05 M
ROE -1016,92% ROA -18,52%
Gross Margin N/A Operating Margin -17,64%
Net Margin -9,07% Free Cash Flow (TTM) -122,87 M
ROIC -82,75% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,32
Interest Coverage -5,51 Asset Turnover 2,04
Working Capital -288,32 M Tangible Book Value -531,60 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,10 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,37
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -22,87%
Market Cap 537,14 M Enterprise Value 752,34 M
Per Share
EPS (Diluted TTM) -22,62 Revenue / Share 7,11
FCF / Share -0,60 OCF / Share -0,60
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,01% FCF Conversion 93,76%
SBC-Adj. FCF -129,31 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2021 FY2022
Revenue 1,50 B 1,27 B 58,76 M 1,05 B
Net Income -135,85 M -57,77 M -10,08 M -270,13 M
EPS (Diluted) -1,08 -0,63 -0,24 -6,50
Gross Profit — — — —
Operating Income -320,66 M -167,93 M -58,89 M -1,56 B
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A 86,06 M 86,68 M 187.558,0 87,29 M
Interest Expense -22,17 M -15,99 M -1,32 M -11,40 M
Income Tax 4,39 M 2,70 M 0,0 1,86 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2021 FY2022
Total Assets 783,42 M 860,97 M 2,36 B 876,57 M
Total Liabilities 633,89 M 427,31 M 299,94 M 353,91 M
Shareholders' Equity 75,94 M 142,13 M 273,55 M 5,85 M
Total Debt 89,82 M 108,32 M 83,62 M 98,00 M
Cash & Equivalents 38,82 M 36,32 M 140,48 M 17,54 M
Current Assets 184,14 M 166,02 M 199,86 M 100,69 M
Current Liabilities 496,42 M 299,37 M 198,77 M 241,66 M